|
1.
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Landgraf P, Rusu M, Sheridan R, et al: A
mammalian microRNA expression atlas based on small RNA library
sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
5.
|
Jazbutyte V and Thum T: MicroRNA-21: from
cancer to cardiovascular disease. Curr Drug Targets. 11:926–935.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Avissar M, McClean MD, Kelsey KT and
Marsit CJ: MicroRNA expression in head and neck cancer associates
with alcohol consumption and survival. Carcinogenesis.
30:2059–2063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Slaby O, Svoboda M, Fabian P, et al:
Altered expression of miR-21, miR-31, miR-143 and miR-145 is
related to clinicopathologic features of colorectal cancer.
Oncology. 72:397–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yamamichi N, Shimomura R, Inada K, et al:
Locked nucleic acid in situ hybridization analysis of miR-21
expression during colorectal cancer development. Clin Cancer Res.
15:4009–4016. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Yan LX, Huang XF, Shao Q, et al: MicroRNA
miR-21 overexpression in human breast cancer is associated with
advanced clinical stage, lymph node metastasis and patient poor
prognosis. RNA. 14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Feber A, Xi L, Luketich JD, et al:
MicroRNA expression profiles of esophageal cancer. J Thorac
Cardiovasc Surg. 135:255–260. 2008. View Article : Google Scholar
|
|
14.
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Thum T, Gross C, Fiedler J, et al:
MicroRNA-21 contributes to myocardial disease by stimulating MAP
kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sayed D, Rane S, Lypowy J, et al:
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol
Biol Cell. 19:3272–3282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wang P, Zou F, Zhang X, et al: microRNA-21
negatively regulates Cdc25A and cell cycle progression in colon
cancer cells. Cancer Res. 69:8157–8165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Sutterluty H, Mayer CE, Setinek U, et al:
Down-regulation of Sprouty2 in non-small cell lung cancer
contributes to tumor malignancy via extracellular signal-regulated
kinase pathway-dependent and -independent mechanisms. Mol Cancer
Res. 5:509–520. 2007. View Article : Google Scholar
|
|
21.
|
Mayer CE, Haigl B, Jantscher F, et al:
Bimodal expression of Sprouty2 during the cell cycle is mediated by
phase-specific Ras/MAPK and c-Cbl activities. Cell Mol Life Sci.
67:3299–3311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Jantscher F, Pirker C, Mayer CE, Berger W
and Sutterluety H: Overexpression of Aurora-A in primary cells
interferes with S-phase entry by diminishing Cyclin D1 dependent
activities. Mol Cancer. 10:282011. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Haigl B, Mayer CE, Siegwart G and
Sutterluty H: Sprouty4 levels are increased under hypoxic
conditions by enhanced mRNA stability and transcription. Biol Chem.
391:813–821. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sutterluety H, Bartl S, Doetzlhofer A,
Khier H, Wintersberger E and Seiser C: Growth-regulated antisense
transcription of the mouse thymidine kinase gene. Nucleic Acids
Res. 26:4989–4995. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Taddei ML, Giannoni E, Fiaschi T and
Chiarugi P: Anoikis: an emerging hallmark in health and diseases. J
Pathol. 226:380–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Markou A, Tsaroucha EG, Kaklamanis L,
Fotinou M, Georgoulias V and Lianidou ES: Prognostic value of
mature microRNA-21 and microRNA-205 overexpression in non-small
cell lung cancer by quantitative real-time RT-PCR. Clin Chem.
54:1696–1704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Voortman J, Goto A, Mendiboure J, et al:
MicroRNA expression and clinical outcomes in patients treated with
adjuvant chemotherapy after complete resection of non-small cell
lung carcinoma. Cancer Res. 70:8288–8298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Seike M, Goto A, Okano T, et al: MiR-21 is
an EGFR-regulated anti-apoptotic factor in lung cancer in
never-smokers. Proc Natl Acad Sci USA. 106:12085–12090. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Frezzetti D, De Menna M, Zoppoli P, et al:
Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
Oncogene. 30:275–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Hatley ME, Patrick DM, Garcia MR, et al:
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.
Cancer Cell. 18:282–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Sempere LF, Preis M, Yezefski T, et al:
Fluorescence-based codetection with protein markers reveals
distinct cellular compartments for altered MicroRNA expression in
solid tumors. Clin Cancer Res. 16:4246–4255. 2010. View Article : Google Scholar
|
|
33.
|
Gaur A, Jewell DA, Liang Y, et al:
Characterization of microRNA expression levels and their biological
correlates in human cancer cell lines. Cancer Res. 67:2456–2468.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Bandres E, Cubedo E, Agirre X, et al:
Identification by real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar
|
|
35.
|
Bremnes RM, Donnem T, Al-Saad S, et al:
The role of tumor stroma in cancer progression and prognosis:
emphasis on carcinoma-associated fibroblasts and non-small cell
lung cancer. J Thorac Oncol. 6:209–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
de Oliveira PE, Zhang L, Wang Z and Lazo
JS: Hypoxia-mediated regulation of Cdc25A phosphatase by p21 and
miR-21. Cell Cycle. 8:3157–3164. 2009.PubMed/NCBI
|
|
37.
|
Kulshreshtha R, Ferracin M, Wojcik SE, et
al: A microRNA signature of hypoxia. Mol Cell Biol. 27:1859–1867.
2007. View Article : Google Scholar
|
|
38.
|
Liu LZ, Li C, Chen Q, et al: MiR-21
induced angiogenesis through AKT and ERK activation and HIF-1alpha
expression. PLoS One. 6:e191392011. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Yu Y, Kanwar SS, Patel BB, et al:
MicroRNA-21 induces stemness by downregulating transforming growth
factor beta receptor 2 (TGFbetaR2) in colon cancer cells.
Carcinogenesis. 33:68–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Yang CH, Yue J, Pfeffer SR, Handorf CR and
Pfeffer LM: MicroRNA miR-21 regulates the metastatic behavior of
B16 melanoma cells. J Biol Chem. 286:39172–39178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Gabriely G, Wurdinger T, Kesari S, et al:
MicroRNA 21 promotes glioma invasion by targeting matrix
metalloproteinase regulators. Mol Cell Biol. 28:5369–5380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
